Primaxin

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage.; Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage.

Commercializzato da:

Merck Sharp & Dohme (New Zealand) Limited

INN (Nome Internazionale):

Cilastatin sodium 571 mg (Equiv. to 500 mg cilastatin acid. Includes 4.6% overage.)

Forma farmaceutica:

Powder for injection

Composizione:

Active: Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage. Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage. Excipient: Sodium bicarbonate

Confezione:

Ampoule, glass, 5x13ml (Monovial), 5 dose units

Classe:

Prescription

Tipo di ricetta:

Prescription

Prodotto da:

Merck Sharp & Dohme Corp

Dettagli prodotto:

Package - Contents - Shelf Life: Ampoule, glass, 5x13ml (Monovial) - 5 dose units - 24 months from date of manufacture stored at or below 25°C 4 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Data dell'autorizzazione:

1996-03-20